VRC01LS

Product Description: VRC01LS is a humanized monoclonal antibody inhibitor targeting the CD4-binding site of HIV-1 envelope glycoprotein (Env). VRC01LS blocks the binding of HIV-1 to host cell CD4 receptor, inhibiting viral entry. VRC01LS is promising for research of HIV-1 infection[1][2].

Applications: COVID-19-anti-virus

Formula: N/A

References: [1]Happe M, et al. Virologic effects of broadly neutralizing antibodies VRC01LS and VRC07-523LS on chronic HIV-1 infection. JCI Insight. 2025 Feb 24;10(4):e181496./[2]Gaudinski MR, et al. Safety and pharmacokinetics of the Fc-modified HIV-1 human monoclonal antibody VRC01LS: A Phase 1 open-label clinical trial in healthy adults. PLoS Med. 2018 Jan 24;15(1):e1002493.

Molecular Weight: N/A

Research Area: Infection

Target: HIV;Virus Protease

• SKU: MEXHY-P991246-0
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-P991246-0
• Package Unit: Get quote
• Quantity Unit: STK
• Conjugate: Unconjugated